VA-GLA Infectious Diseases
  • Home
  • News
  • Services
  • ASP Main Page Antibiotic Approvals Antibiotics Restricted to Guidelines Switching from IV to PO Antibiotic Timeouts Rapid Diagnostics at GLA ID in seconds
  • GLA Guidelines Needlestick Injury TB Isolation
  • Susceptibilities
  • ID fellow resources
  • Links Board Review slides Teaching Documents

VA-GLA Infectious Diseases

  • Home/
  • News/
  • Services/
  • Stewardship/
    • ASP Main Page
    • Antibiotic Approvals
    • Antibiotics Restricted to Guidelines
    • Switching from IV to PO
    • Antibiotic Timeouts
    • Rapid Diagnostics at GLA
    • ID in seconds
  • Guidelines/
    • GLA Guidelines
    • Needlestick Injury
    • TB Isolation
  • Susceptibilities/
  • ID fellow resources/
  • Other/
    • Links
    • Board Review slides
    • Teaching Documents

VA-GLA Infectious Diseases

VA-GLA Infectious Diseases

New and Noteworthy

VA-GLA Infectious Diseases

  • Home/
  • News/
  • Services/
  • Stewardship/
    • ASP Main Page
    • Antibiotic Approvals
    • Antibiotics Restricted to Guidelines
    • Switching from IV to PO
    • Antibiotic Timeouts
    • Rapid Diagnostics at GLA
    • ID in seconds
  • Guidelines/
    • GLA Guidelines
    • Needlestick Injury
    • TB Isolation
  • Susceptibilities/
  • ID fellow resources/
  • Other/
    • Links
    • Board Review slides
    • Teaching Documents
August 01, 2019

Ampicillin-sulbactam shortage

August 01, 2019/ VAGLA Antimicrobial Stewardship Team

There is currently a nationwide shortage of ampicillin-sulbactam. Until it is resolved, ampicillin-sulbactam use will require approval from the infectious diseases consult service. Ceftriaxone plus metronidazole is an acceptable substitute in many situations where ampicillin-sulbactam is commonly used.

August 01, 2019/ VAGLA Antimicrobial Stewardship Team/

VAGLA Antimicrobial Stewardship Team

  • IDWeek 2019 poster!
  • New PCR-based GI panel for stool ...